Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb 3;7(1):3-9.
doi: 10.3390/pharmaceutics7010003.

Influence of chronobiology on the nanoparticle-mediated drug uptake into the brain

Affiliations
Review

Influence of chronobiology on the nanoparticle-mediated drug uptake into the brain

Jörg Kreuter. Pharmaceutics. .

Abstract

Little attention so-far has been paid to the influence of chronobiology on the processes of nanoparticle uptake and transport into the brain, even though this transport appears to be chronobiologically controlled to a significant degree. Nanoparticles with specific surface properties enable the transport across the blood-brain barrier of many drugs that normally cannot cross this barrier. A clear dependence of the central antinociceptive (analgesic) effects of a nanoparticle-bound model drug, i.e., the hexapeptide dalargin, on the time of day was observable after intravenous injection in mice. In addition to the strongly enhanced antinociceptive effect due to the binding to the nanoparticles, the minima and maxima of the pain reaction with the nanoparticle-bound drug were shifted by almost half a day compared to the normal circadian nociception: The maximum in the pain reaction after i.v. injection of the nanoparticle-bound dalargin occurred during the later rest phase of the animals whereas the normal pain reaction and that of a dalargin solution was highest during the active phase of the mice in the night. This important shift could be caused by an enhanced endo- and exocytotic particulates transport activity of the brain capillary endothelial cells or within the brain during the rest phase.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Dependence of the reaction times (s) in the hot-plate test 15 min after intravenous injection of 10 mg/kg of a dalargin solution (DAL/SOL) or of dalargin-coated nanoparticles (DAL/NP) on the time of day. Groups of 10–12 DAB/2 mice were tested every 2 h within 24 h; lights on from 07:00 to 19:00. Shown are mean values ± SEM; the solid line represents the cosine fit to the data. (Adapted with permission from [13]. Copyright 1999 Informa Healthcare).
Figure 2
Figure 2
Dose-response effects of dalargin-coated nanoparticles. Response determined 15 min after intravenous injection (DAL/NP, 2.5–10 mg/kg) at either 08:00 or 20:00; lights on from 07:00 to 19:00. Shown are mean values ± SEM of the maximal possible effect (% MPE. Adapted with permission from [13]. Copyright 1999 Informa Healthcare).

Similar articles

Cited by

References

    1. Davson H., Segal M. Physiology of the CSF and Blood–Brain Barrier. CRC Press; Boca Raton, FL, USA: 1996.
    1. Begley D.J. The blood-brain barrier: Principles for targeting peptides and drugs to the central nervous system. J. Pharm. Pharmacol. 1996;48:136–146. doi: 10.1111/j.2042-7158.1996.tb07112.x. - DOI - PubMed
    1. Begley D.J. Delivery of therapeutic agents to the central nervous system: The problems and possibilities. Pharmacol. Ther. 2004;104:29–45. doi: 10.1016/j.pharmthera.2004.08.001. - DOI - PubMed
    1. Kreuter J. Drug delivery to the central nervous system by polymeric nanoparticles: What do we know? Adv. Drug Deliv. Rev. 2014;71:2–14. doi: 10.1016/j.addr.2013.08.008. - DOI - PubMed
    1. Wohlfart S., Gelperina S., Kreuter J. Transport of drugs across the blood-brain barrier by nanoparticles. J. Control. Release. 2012;161:264–273. doi: 10.1016/j.jconrel.2011.08.017. - DOI - PubMed

LinkOut - more resources